Follow
Kylie Morphett
Kylie Morphett
Research Fellow, School of Public Health, University of Queensland
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
Why Don’t Smokers Want Help to Quit? A Qualitative Study of Smokers’ Attitudes towards Assisted vs. Unassisted Quitting
K Morphett, B Partridge, C Gartner, A Carter, W Hall
International Journal of Environmental Research and Public Health 12 (6 …, 2015
912015
Neurobehavioral differences between Alzheimer's disease and frontotemporal dementia: a meta-analysis
JL Mathias, K Morphett
Journal of clinical and experimental neuropsychology 32 (7), 682-698, 2010
542010
Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and …
DA Erku, S Kisely, K Morphett, KJ Steadman, CE Gartner
International Journal of Drug Policy 78, 102699, 2020
382020
Public attitudes in A ustralia towards the claim that addiction is a (brain) disease
C Meurk, B Partridge, A Carter, W Hall, K Morphett, J Lucke
Drug and alcohol review 33 (3), 272-279, 2014
362014
Closing the gaps in tobacco endgame evidence: a scoping review
C Puljević, K Morphett, M Hefler, R Edwards, N Walker, DP Thomas, ...
Tobacco control 31 (2), 365-375, 2022
322022
Beliefs and self-reported practices of health care professionals regarding electronic nicotine delivery systems: a mixed-methods systematic review and synthesis
DA Erku, CE Gartner, K Morphett, KJ Steadman
Nicotine and Tobacco Research 22 (5), 619-629, 2020
312020
Scepticism and hope in a complex predicament: People with addictions deliberate about neuroscience
C Meurk, K Morphett, A Carter, M Weier, J Lucke, W Hall
International Journal of Drug Policy 32, 34-43, 2016
292016
What does ‘acceptance’mean? Public reflections on the idea that addiction is a brain disease
C Meurk, W Hall, K Morphett, A Carter, J Lucke
BioSocieties 8, 491-506, 2013
252013
Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A …
DA Erku, L Bauld, L Dawkins, CE Gartner, KJ Steadman, SM Noar, ...
Addiction 116 (12), 3290-3303, 2021
232021
Policy debates regarding nicotine vaping products in Australia: a qualitative analysis of submissions to a government inquiry from health and medical organisations
DA Erku, K Morphett, KJ Steadman, CE Gartner
International Journal of Environmental Research and Public Health 16 (22), 4555, 2019
222019
Smokers’ understandings of addiction to nicotine and tobacco: a systematic review and interpretive synthesis of quantitative and qualitative research
D Pfeffer, B Wigginton, C Gartner, K Morphett
Nicotine and tobacco research 20 (9), 1038-1046, 2018
222018
Framing tobacco dependence as a “brain disease”: Implications for policy and practice
K Morphett, A Carter, W Hall, C Gartner
Nicotine & Tobacco Research 19 (7), 774-780, 2017
222017
Electronic nicotine delivery systems (e-cigarettes) as a smoking cessation aid: a survey among pharmacy staff in Queensland, Australia
DA Erku, CE Gartner, JT Do, K Morphett, KJ Steadman
Addictive behaviors 91, 227-233, 2019
212019
Barriers and facilitators to switching from smoking to vaping: Advice from vapers
K Morphett, M Weier, R Borland, HH Yong, C Gartner
Drug and alcohol review 38 (3), 234-243, 2019
212019
Medicalisation, smoking and e-cigarettes: evidence and implications
K Morphett, A Carter, W Hall, C Gartner
Tobacco control 26 (e2), e134-e139, 2017
192017
Predicting vaping uptake, vaping frequency and ongoing vaping among daily smokers using longitudinal data from the International Tobacco Control (ITC) Four Country Surveys
G Chan, K Morphett, C Gartner, J Leung, HH Yong, W Hall, R Borland
Addiction 114, 61-70, 2019
172019
A first pass, using pre‐history and contemporary history, at understanding why Australia and England have such different policies towards electronic nicotine delivery systems …
V Berridge, W Hall, S Taylor, C Gartner, K Morphett
Addiction 116 (9), 2577-2585, 2021
142021
A qualitative study of smokers’ views on brain-based explanations of tobacco dependence
K Morphett, A Carter, W Hall, C Gartner
International Journal of Drug Policy 29, 41-48, 2016
142016
Public attitudes toward the treatment of nicotine addiction
K Morphett, J Lucke, C Gartner, A Carter, C Meurk, W Hall
nicotine & tobacco research 15 (9), 1617-1622, 2013
142013
Nicotine vaping product use, harm perception and policy support among pharmacy customers in Brisbane, Australia
DA Erku, CE Gartner, U Tengphakwaen, K Morphett, KJ Steadman
Drug and Alcohol Review 38 (6), 703-711, 2019
132019
The system can't perform the operation now. Try again later.
Articles 1–20